TWO SIGMA INVESTMENTS, LP

Position in IVVD — Invivyd, Inc.

CIK 1179392 NEW YORK, NY

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,034,789

-$525,767 QoQ

Shares Held

2,333,474

+18.5% QoQ

Ownership

0.792%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 124 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. IVVD ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,034,789	2,333,474	+18.5%	Shares	Sole	2026-08-14
2026-03-31	$2,560,556	1,969,659	-10.1%	Shares	Sole	2026-05-15
2025-12-31	$5,413,993	2,191,900	+554.3%	Shares	Sole	2026-02-17
2025-09-30	$368,500	335,000	+40.3%	Shares	Sole	2025-11-14
2025-06-30	$170,664	238,692	-0.8%	Shares	Sole	2025-08-14
2025-03-31	$145,567	240,607	-34.5%	Shares	Sole	2025-05-15
2024-12-31	$162,625	367,100	+125.3%	Shares	Sole	2025-02-14
2024-09-30	$166,170	162,912	-54.2%	Shares	Sole	2024-11-14
2024-06-30	$391,183	355,621	+161.9%	Shares	Sole	2024-08-14
2024-03-31	$602,778	135,761	+138.8%	Shares	Sole	2024-05-15
2023-12-31	$224,004	56,854	+139.8%	Shares	Sole	2024-02-14
2021-09-30	$1,001,637	23,713	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.